Mark Rockley
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mark Rockley has a total of 144 co-authors. Here are the top co-authors by number of shared publications:
- Prasad Jetty
Division of Vascular Surgery, University of Ottawa, Ottawa, Ontario, Canada
5 shared publications Prasad Jetty
Division of Vascular and Endovascular Surgery, Department of Surgery, University of Ottawa, Ottawa, Ontario, Canada
4 shared publicationsAdnan Hadziomerovic
University of Ottawa, Ottawa, Ontario, Canada
3 shared publicationsGeorge Wells
University of Ottawa, Ottawa, Ontario, Canada
3 shared publications- Kenton Rommens
Libin Cardiovascular Institute, Calgary, Alberta, Canada
3 shared publications Randy D. Moore
3 shared publications
Latest Publications
- Open Access
- 31 January 2025
- Published by Elsevier in JVS-Vascular Insights
- Vol. 3
Long-term outcomes of neoaortoiliac system for treatment of aortic graft infection
- 31 January 2025
- Published by Elsevier in JVS-Vascular Insights
- Vol. 3
Open AccessLong-term outcomes of neoaortoiliac system for treatment of aortic graft infection
- 7 June 2024
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 67 (6) , e92
A procedural step analysis of radiation exposure in fenestrated endovascular aortic repair
- 7 June 2024
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 67 (6) , e92
A procedural step analysis of radiation exposure in fenestrated endovascular aortic repair
- 16 February 2024
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 79 (6) , 1306-1314.e2
A procedural step analysis of radiation exposure in fenestrated endovascular aortic repair
- 16 February 2024
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 79 (6) , 1306-1314.e2
A procedural step analysis of radiation exposure in fenestrated endovascular aortic repair
- Open Access
- 12 August 2023
- Published by Elsevier in Annals of Thoracic Surgery Short Reports
- Vol. 2 (1) , 11-14
Total Aortic Arch Endograft and Double In Situ Fenestration for Aortobronchial Fistula
- 12 August 2023
- Published by Elsevier in Annals of Thoracic Surgery Short Reports
- Vol. 2 (1) , 11-14
Open AccessTotal Aortic Arch Endograft and Double In Situ Fenestration for Aortobronchial Fistula
- Open Access
- 27 July 2023
- Published by Elsevier in Journal of Vascular Surgery Cases, Innovations and Techniques
- Vol. 9 (4) , 101274
Aortic arch endovascular branch and fenestrated repair: Initial Canadian experience with novel technology
- 27 July 2023
- Published by Elsevier in Journal of Vascular Surgery Cases, Innovations and Techniques
- Vol. 9 (4) , 101274
Open AccessAortic arch endovascular branch and fenestrated repair: Initial Canadian experience with novel technology
- Open Access
- 21 June 2023
- Published by Elsevier in Journal of Vascular Surgery Cases, Innovations and Techniques
- Vol. 9 (2) , 101248
Contents
- 21 June 2023
- Published by Elsevier in Journal of Vascular Surgery Cases, Innovations and Techniques
- Vol. 9 (2) , 101248
Open AccessContents
- 14 October 2021
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 79, 427-431
Physician-modified steerable endovascular catheter
- 14 October 2021
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 79, 427-431
Physician-modified steerable endovascular catheter
- 1 September 2021
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 74 (3) , e251-e252
Intraoperative Simultaneous Limb Perfusion Monitoring (INSTANT) Study
- 1 September 2021
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 74 (3) , e251-e252
Intraoperative Simultaneous Limb Perfusion Monitoring (INSTANT) Study
- 18 February 2021
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 77 (4) , 450-457
Revisiting the Evidence for Dipyridamole in Reducing Restenosis: A Systematic Review and Meta-analysis
Atherosclerosis remains a leading cause of morbidity and mortality, with revascularization remaining a cornerstone of management. Conventional revascularization modalities remain challenged by target vessel re-occlusion – an event driven by mechanical, thrombotic and proliferative processes. Despite considerable advancements, restenosis remains the focus of ongoing research. Adjunctive agents, including dipyridamole, offer a multitude of effects which may improve vascular homeostasis. We sought to quantify the potential therapeutic impact of dipyridamole on vascular occlusion. We performed a literature search (EMBASE, Medline) examining studies which encompassed three areas: (1) one of the designated medical therapies applied in (2) the setting of a vascular intervention with (3) an outcome including vascular occlusion rates and/or quantification of neointimal proliferation/restenosis. The primary outcome was vascular occlusion rates. Secondary outcome was the degree of restenosis by neointimal quantification. Both human and animal studies were included in this translational analysis. 6,839 articles were screened from which 73 studies were included, encompassing 16,146 vessels followed up for a mean 327.3 days (range 7-3650 days). Pre-clinical studies demonstrate that dipyridamole results in reduced vascular occlusion rates (24.9% versus 48.8%, RR 0.53 [95% CI 0.40-0.70], I2 = 39%, p2=91%, p=0.0002). Clinical studies similarly demonstrated reduced occlusion rates with dipyridamole therapy (23.5% versus 31.0%, RR 0.77[95% CI 0.67-0.88], I2=84%, p<0.0001). Dipyridamole may improve post-intervention vascular patency and mitigate restenosis. Dedicated studies are warranted to delineate its role as an adjunctive agent following revascularization.
- 18 February 2021
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 77 (4) , 450-457
Revisiting the Evidence for Dipyridamole in Reducing Restenosis: A Systematic Review and Meta-analysis
Atherosclerosis remains a leading cause of morbidity and mortality, with revascularization remaining a cornerstone of management. Conventional revascularization modalities remain challenged by target vessel re-occlusion – an event driven by mechanical, thrombotic and proliferative processes. Despite considerable advancements, restenosis remains the focus of ongoing research. Adjunctive agents, including dipyridamole, offer a multitude of effects which may improve vascular homeostasis. We sought to quantify the potential therapeutic impact of dipyridamole on vascular occlusion. We performed a literature search (EMBASE, Medline) examining studies which encompassed three areas: (1) one of the designated medical therapies applied in (2) the setting of a vascular intervention with (3) an outcome including vascular occlusion rates and/or quantification of neointimal proliferation/restenosis. The primary outcome was vascular occlusion rates. Secondary outcome was the degree of restenosis by neointimal quantification. Both human and animal studies were included in this translational analysis. 6,839 articles were screened from which 73 studies were included, encompassing 16,146 vessels followed up for a mean 327.3 days (range 7-3650 days). Pre-clinical studies demonstrate that dipyridamole results in reduced vascular occlusion rates (24.9% versus 48.8%, RR 0.53 [95% CI 0.40-0.70], I2 = 39%, p2=91%, p=0.0002). Clinical studies similarly demonstrated reduced occlusion rates with dipyridamole therapy (23.5% versus 31.0%, RR 0.77[95% CI 0.67-0.88], I2=84%, p<0.0001). Dipyridamole may improve post-intervention vascular patency and mitigate restenosis. Dedicated studies are warranted to delineate its role as an adjunctive agent following revascularization.
- Open Access
- 1 December 2020
- Published by Elsevier in Journal of Vascular Surgery Cases, Innovations and Techniques
- Vol. 6 (4) , 520-523
Endarterectomy of carotid artery bifurcation in the setting of a persistent hypoglossal artery and anomalous collateral vascular supply
- 1 December 2020
- Published by Elsevier in Journal of Vascular Surgery Cases, Innovations and Techniques
- Vol. 6 (4) , 520-523
Open AccessEndarterectomy of carotid artery bifurcation in the setting of a persistent hypoglossal artery and anomalous collateral vascular supply